纳微科技1月29日获融资买入2268.86万元，融资余额3.45亿元

Group 1 - The core business of Suzhou Nanwei Technology Co., Ltd. involves the research, large-scale production, sales, and application services of high-performance nano microsphere materials, serving clients in biomedicine, flat panel displays, analytical testing, and in vitro diagnostics [2] - As of September 30, 2025, Nanwei Technology achieved a revenue of 671 million yuan, representing a year-on-year growth of 22.01%, and a net profit attributable to shareholders of 108 million yuan, with a significant increase of 156.56% [2] - The company has distributed a total of 115 million yuan in dividends since its A-share listing, with 86.84 million yuan distributed over the past three years [3] Group 2 - On January 29, 2025, Nanwei Technology's stock price increased by 1.94%, with a trading volume of 233 million yuan [1] - The financing data on January 29 indicates that Nanwei Technology had a net financing buy of -12.20 million yuan, with a total financing balance of 347 million yuan, accounting for 3.01% of its market capitalization [1] - The short selling data shows that on January 29, 800 shares were repaid and 500 shares were sold short, with a short selling balance of 1.35 million yuan, which is above the 90th percentile level over the past year [1]